Zobrazeno 1 - 7
of 7
pro vyhledávání: '"L Balade Martinez"'
Autor:
T Perez Robles, M de Sebastian Rueda, A Herrero Ambrosio, L Balade Martinez, JA Romero Garrido, E Rodriguez Martin
Publikováno v:
European Journal of Hospital Pharmacy. 23:A14.1-A14
Background Eltrombopag is a thrombopoietin receptor agonist (TRA). The drug has been approved for the treatment of chronic immune thrombocytopenia (ITP). The platelet (PLT) count response is usually maintained as long as the medication is continued,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a8342ae513f49c57df41b68ba1b111c
https://doi.org/10.1136/ejhpharm-2016-000875.32
https://doi.org/10.1136/ejhpharm-2016-000875.32
Autor:
I Jiménez Nácher, F Moreno Ramos, B. Benítez García, L Martin Carbonero, L Balade Martinez, M. A. González Fernández, Ml Montes Ramirez, L González del Valle, A Herrero Ambrosio, A Olveira Martin
Publikováno v:
European Journal of Hospital Pharmacy. 23:A67.2-A68
Background Recently, new direct acting antivirals (DAAs) for chronic hepatitis C have been licensed. These drugs achieve a virologic sustained response (SVR) above 90% in clinical trials. SVR is defined as undetectable HCV RNA 12 weeks after treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14f6823165fb29b4a9ac85b8044bdae5
https://doi.org/10.1136/ejhpharm-2016-000875.153
https://doi.org/10.1136/ejhpharm-2016-000875.153
Autor:
M Molina Cabezuelo, L González del Valle, L Balade Martinez, E Rodriguez Martin, M de Sebastian Rueda, A Herrero Ambrosio
Publikováno v:
European Journal of Hospital Pharmacy. 23:A27.2-A28
Background Hepatic veno-occlusive (VOD) disease is a potentially life threatening complication that mainly occurs after myeloablative conditioning therapy and haematopoietic stem cell transplantation (HSCT). The disease is characterised by increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f55c3e139bb994de545a293034d8b0f
https://doi.org/10.1136/ejhpharm-2016-000875.62
https://doi.org/10.1136/ejhpharm-2016-000875.62
Autor:
S Andrés Morera, M Ruiz de Hoyos, MJ De Domingo Gadea, L Balade Martinez, M Moro Agud, A Herrero Ambrosio
Publikováno v:
European Journal of Hospital Pharmacy. 23:A21.1-A21
Background The use of STOPP/START criteria is part of the daily routine during pharmaceutical validation. One important pharmaceutical intervention is to recommend digoxin dose adjustment in elderly patients when it is prescribed 0.25 mg/day. Digoxin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::602212ddc9d25f60fbc4eb284b603306
https://doi.org/10.1136/ejhpharm-2016-000875.47
https://doi.org/10.1136/ejhpharm-2016-000875.47
Autor:
L Balade Martinez, HA Varela Fernández, M. A. González Fernández, A Herrero Ambrosio, C Rueda Perez
Publikováno v:
European Journal of Hospital Pharmacy. 21:A4.3-A5
Background The search for effective treatment in idiopathic pulmonary fibrosis (IPF) has involved numerous clinical trials without significant success. However, in 2011, pirfenidone was the first drug to be approved for the treatment of IPF in Europe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84f019ce9450b92d2ca8680e3fa6d63e
https://doi.org/10.1136/ejhpharm-2013-000436.11
https://doi.org/10.1136/ejhpharm-2013-000436.11
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.